The cysteine protease α-Clostripain is not essential for the pathogenesis of clostridium Perfringens-Mediated myonecrosis

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Chakravorty, Anjana ^a   Awad, Milena M ^a   Hiscox, Thomas J ^a   Cheung, Jackie K ^a   Carter, Glen P ^a   Choo, Jocelyn M ^a   Lyras, Dena ^a   Rood, Julian I ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; ALPHA CLOSTRIPAIN; CYSTEINE PROTEINASE; UNCLASSIFIED DRUG; BACTERIAL TOXIN; CLOSTRIDIUM PERFRINGENS THETA TOXIN; CLOSTRIDIUM PERFRINGENS THETA-TOXIN; CLOSTRIPAIN; HEMOGLOBIN; HEMOLYSIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BACTERIAL VIRULENCE; CCP GENE; CLOSTRIDIUM PERFRINGENS; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; FEMALE; GENE CONSTRUCT; GENE MUTATION; GENETIC COMPLEMENTATION; HISTOPATHOLOGY; MILK; MOUSE; MUSCLE NECROSIS; NONHUMAN; PATHOGENESIS; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN SECRETION; STRUCTURAL GENE; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CELL SURVIVAL; CLOSTRIDIUM INFECTION; CYTOLOGY; DISEASE MODEL; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MICROBIOLOGY; MUTATION; NECROSIS; PATHOGENICITY; SKELETAL MUSCLE; SURVIVAL RATE; VIRULENCE;

CLOSTRIDIUM PERFRINGENS;

ANIMALS; BACTERIAL TOXINS; CELL SURVIVAL; CELLS, CULTURED; CLOSTRIDIUM INFECTIONS; CLOSTRIDIUM PERFRINGENS; CYSTEINE ENDOPEPTIDASES; DISEASE MODELS, ANIMAL; FEMALE; HEMOGLOBINS; HEMOLYSIN PROTEINS; MICE; MICE, INBRED BALB C; MUSCLE, SKELETAL; MUTAGENESIS, INSERTIONAL; MUTATION; NECROSIS; SURVIVAL RATE; VIRULENCE;

EID: 79960901979     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022762     Document Type: Article

References (56)

1. Awad MM, Bryant AE, Stevens DL, Rood JI, (1995) Virulence studies on chromosomal alpha-toxin and theta-toxin mutants constructed by allelic exchange provide genetic evidence for the essential role of alpha-toxin in Clostridium perfringens-mediated gas gangrene. Mol Microbiol 15: 191-202.
2. Rood JI, (1998) Virulence genes of Clostridium perfringens. Annu Rev Microbiol 52: 333-360.
3. Awad MM, Ellemor DM, Bryant AE, Matsushita O, Boyd RL, et al. (2000) Construction and virulence testing of a collagenase mutant of Clostridium perfringens. Microb Pathog 28: 107-117.
4. Bryant AE, Chen RY, Nagata Y, Wang Y, Lee CH, et al. (2000) Clostridial gas gangrene. I. Cellular and molecular mechanisms of microvascular dysfunction induced by exotoxins of Clostridium perfringens. J Infect Dis 182: 799-807.
5. Stevens DL, Bryant AE, (1997) Pathogenesis of Clostridium perfringens infection: mechanisms and mediators of shock. Clin Infect Dis 25 (Suppl 2): S160-164.
6. Ellemor DM, Baird RN, Awad MM, Boyd RL, Rood JI, et al. (1999) Use of genetically manipulated strains of Clostridium perfringens reveals that both alpha-toxin and theta-toxin are required for vascular leukostasis to occur in experimental gas gangrene. Infect Immun 67: 4902-4907.
7. Awad MM, Ellemor DM, Boyd RL, Emmins JJ, Rood JI, (2001) Synergistic effects of alpha-toxin and perfringolysin O in Clostridium perfringens-mediated gas gangrene. Infect Immun 69: 7904-7910.
8. Gilles AM, Imhoff JM, Keil B, (1979) alpha-Clostripain. Chemical characterization, activity, and thiol content of the highly active form of clostripain. J Biol Chem 254: 1462-1468.
9. Gilles AM, Lecroisey A, Keil B, (1984) Primary structure of alpha-clostripain light chain. Eur J Biochem 145: 469-476.
10. Gilles AM, Keil B, (1984) Evidence for an active-center cysteine in the SH-proteinase alpha-clostripain through use of N-tosyl-L-lysine chloromethyl ketone. FEBS Lett 173: 58-62.
11. Shimizu T, Ohshima S, Ohtani K, Hayashi H, (2001) Genomic map of Clostridium perfringens strain 13. Microbiol Immunol 45: 179-189.
12. Labrou NE, Rigden DJ, (2004) The structure-function relationship in the clostripain family of peptidases. Eur J Biochem 271: 983-992.
13. Tanaka H, Tamai E, Miyata S, Taniguchi Y, Nariya H, et al. (2008) Construction and characterization of a clostripain-like protease-deficient mutant of Clostridium perfringens as a strain for clostridial gene expression. Appl Microbiol Biotechnol 77: 1063-1071.
14. Okumura K, Ohtani K, Hayashi H, Shimizu T, (2008) Characterization of genes regulated directly by the VirR/VirS system in Clostridium perfringens. J Bacteriol 190: 7719-7727.
15. Dargatz H, Diefenthal T, Witte V, Reipen G, von Wettstein D, (1993) The heterodimeric protease clostripain from Clostridium histolyticum is encoded by a single gene. Mol Gen Genet 240: 140-145.
16. Manabe S, Nariya H, Miyata S, Tanaka H, Minami J, et al. (2010) Purification and characterization of a clostripain-like protease from a recombinant Clostridium perfringens culture. Microbiology 156: 561-569.
17. Baba A, Kadowaki T, Asao T, Yamamoto K, (2002) Roles for Arg- and Lys-gingipains in the disruption of cytokine responses and loss of viability of human endothelial cells by Porphyromonas gingivalis infection. Biol Chem 383: 1223-1230.
18. Calkins CC, Platt K, Potempa J, Travis J, (1998) Inactivation of tumor necrosis factor-alpha by proteinases (gingipains) from the periodontal pathogen, Porphyromonas gingivalis. Implications of immune evasion. J Biol Chem 273: 6611-6614.
19. Lourbakos A, Potempa J, Travis J, D'Andrea MR, Andrade-Gordon P, et al. (2001) Arginine-specific protease from Porphyromonas gingivalis activates protease-activated receptors on human oral epithelial cells and induces interleukin-6 secretion. Infect Immun 69: 5121-5130.
20. Lourbakos A, Yuan YP, Jenkins AL, Travis J, Andrade-Gordon P, et al. (2001) Activation of protease-activated receptors by gingipains from Porphyromonas gingivalis leads to platelet aggregation: a new trait in microbial pathogenicity. Blood 97: 3790-3797.
21. Banbula A, Bugno M, Kuster A, Heinrich PC, Travis J, et al. (1999) Rapid and efficient inactivation of IL-6 gingipains, lysine- and arginine-specific proteinases from Porphyromonas gingivalis. Biochem Biophys Res Commun 261: 598-602.
22. Collin M, Olsen A, (2001) Effect of SpeB and EndoS from Streptococcus pyogenes on human immunoglobulins. Infect Immun 69: 7187-7189.
23. Collin M, Svensson MD, Sjoholm AG, Jensenius JC, Sjobring U, et al. (2002) EndoS and SpeB from Streptococcus pyogenes inhibit immunoglobulin-mediated opsonophagocytosis. Infect Immun 70: 6646-6651.
24. Terao Y, Mori Y, Yamaguchi M, Shimizu Y, Ooe K, et al. (2008) Group A streptococcal cysteine protease degrades C3 (C3b) and contributes to evasion of innate immunity. J Biol Chem 283: 6253-6260.
25. Tanaka T, Yamamoto T, Tsukiji S, Nagamune T, (2008) Site-specific protein modification on living cells catalyzed by Sortase. Chembiochem 9: 802-807.
26. Shimizu T, Shima K, Yoshino K, Yonezawa K, Hayashi H, (2002) Proteome and transcriptome analysis of the virulence genes regulated by the VirR/VirS system in Clostridium perfringens. J Bacteriol 184: 2587-2594.
27. Cheung JK, Keyburn AL, Carter GP, Lanckriet AL, Van Immerseel F, et al. (2010) The VirSR two-component signal transduction system regulates NetB toxin production in Clostridium perfringens. Infect Immun 78: 3064-3072.
28. Payne SM, (1993) Iron acquisition in microbial pathogenesis. Trends Microbiol 1: 66-69.
29. Sijwali PS, Brinen LS, Rosenthal PJ, (2001) Systematic optimization of expression and refolding of the Plasmodium falciparum cysteine protease falcipain-2. Protein Expr Purif 22: 128-134.
30. Sijwali PS, Shenai BR, Gut J, Singh A, Rosenthal PJ, (2001) Expression and characterization of the Plasmodium falciparum haemoglobinase falcipain-3. Biochem J 360: 481-489.
31. Kida Y, Shimizu T, Kuwano K, (2011) Cooperation between LepA and PlcH contributes to the in vivo virulence and growth of Pseudomonas aeruginosa in mice. Infect Immun 79: 211-219.
32. Jozwiak J, Komar A, Jankowska E, Martirosian G, (2005) Determination of the cytotoxic effect of Clostridium histolyticum culture supernatant on HeLa cells in the presence of protease inhibitors. FEMS Immunol Med Microbiol 45: 137-142.
33. Stathopoulou PG, Galicia JC, Benakanakere MR, Garcia CA, Potempa J, et al. (2009) Porphyromonas gingivalis induce apoptosis in human gingival epithelial cells through a gingipain-dependent mechanism. BMC Microbiol 9: 107.
34. Tanaka H, Nariya H, Suzuki M, Houchi H, Tamai E, et al. (2011) High-level production and purification of clostripain expressed in a virulence-attenuated strain of Clostridium perfringens. Protein Expr Purif 76: 83-89.
35. Kennedy CL, Lyras D, Cheung JK, Hiscox TJ, Emmins JJ, et al. (2009) Cross-complementation of Clostridium perfringens PLC and Clostridium septicum alpha-toxin mutants reveals PLC is sufficient to mediate gas gangrene. Microbes Infect 11: 413-418.
36. Kennedy CL, Lyras D, Cordner LM, Melton-Witt J, Emmins JJ, et al. (2009) Pore-forming activity of alpha-toxin is essential for Clostridium septicum-mediated myonecrosis. Infect Immun 77: 943-951.
37. Bryant AE, (2003) Biology and pathogenesis of thrombosis and procoagulant activity in invasive infections caused by group A streptococci and Clostridium perfringens. Clin Microbiol Rev 16: 451-462.
38. Bryant AE, Bayer CR, Aldape MJ, Wallace RJ, Titball RW, et al. (2006) Clostridium perfringens phospholipase C-induced platelet/leukocyte interactions impede neutrophil diapedesis. J Med Microbiol 55: 495-504.
39. Bryant AE, Bayer CR, Hayes-Schroer SM, Stevens DL, (2003) Activation of platelet gpIIbIIIa by phospholipase C from Clostridium perfringens involves store-operated calcium entry. J Infect Dis 187: 408-417.
40. Hickey MJ, Kwan RY, Awad MM, Kennedy CL, Young LF, et al. (2008) Molecular and cellular basis of microvascular perfusion deficits induced by Clostridium perfringens and Clostridium septicum. PLoS Pathog 4: e1000045.
41. Tamai E, Miyata S, Tanaka H, Nariya H, Suzuki M, et al. (2008) High-level expression of his-tagged clostridial collagenase in Clostridium perfringens. Appl Microbiol Biotechnol 80: 627-635.
42. Takeyama M, Mori H, Nagareda T, Kuroda H, Yamane T, et al. (1986) A case of nontraumatic clostridial gas gangrene occurring in a patient with colon adenocarcinoma, liver cirrhosis, and diabetes mellitus. Acta Pathol Jpn 36: 757-764.
43. Tokuda M, Chen W, Karunakaran T, Kuramitsu HK, (1998) Regulation of protease expression in Porphyromonas gingivalis. Infect Immun 66: 5232-5237.
44. Tokuda M, Duncan M, Cho MI, Kuramitsu HK, (1996) Role of Porphyromonas gingivalis protease activity in colonization of oral surfaces. Infect Immun 64: 4067-4073.
45. Chiarezza M, Lyras D, Pidot SJ, Flores-Diaz M, Awad MM, et al. (2009) The NanI and NanJ sialidases of Clostridium perfringens are not essential for virulence. Infect Immun 77: 4421-4428.
46. Lyristis M, Bryant AE, Sloan J, Awad MM, Nisbet IT, et al. (1994) Identification and molecular analysis of a locus that regulates extracellular toxin production in Clostridium perfringens. Mol Microbiol 12: 761-777.
47. Rood JI, Maher EA, Somers EB, Campos E, Duncan CL, (1978) Isolation and characterization of multiply antibiotic-resistant Clostridum perfringens strains from porcine feces. Antimicrob Agents Chemother 13: 871-880.
48. O'Connor JR, Lyras D, Farrow KA, Adams V, Powell DR, et al. (2006) Construction and analysis of chromosomal Clostridium difficile mutants. Mol Microbiol 61: 1335-1351.
49. Roberts I, Holmes WM, Hylemon PB, (1986) Modified plasmid isolation method for Clostridium perfringens and Clostridium absonum. Appl Environ Microbiol 52: 197-199.
50. Morelle G, (1989) A plasmid extraction procedure on a miniprep scale. Focus 11: 7-8.
51. Sambrook J, Russell DW, (2001) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY Cold Spring Harbor Laboratory Press.
52. Scott PT, Rood JI, (1989) Electroporation-mediated transformation of lysostaphin-treated Clostridium perfringens. Gene 82: 327-333.
53. Bannam TL, Rood JI, (1999) Identification of structural and functional domains of the tetracycline efflux protein TetA(P) from Clostridium perfringens. Microbiology 145: 2947-2955.
54. Sloan J, Warner TA, Scott PT, Bannam TL, Berryman DI, et al. (1992) Construction of a sequenced Clostridium perfringens-Escherichia coli shuttle plasmid. Plasmid 27: 207-219.
55. Stevens DL, Mitten J, Henry C, (1987) Effects of alpha and theta toxins from Clostridium perfringens on human polymorphonuclear leukocytes. J Infect Dis 156: 324-333.
56. Awad MM, Rood JI, (1997) Isolation of alpha-toxin, theta-toxin and kappa-toxin mutants of Clostridium perfringens by Tn916 mutagenesis. Microb Pathog 22: 275-284.